Vornorexant is a dual orexin receptor antagonist (DORA) being developed by Taisho Pharmaceutical for the treatment of insomnia and sleep apnea. 5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine is a key intermediate in the synthesis of vornerexant (also known as ORN-0829 or TS-142).
5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine
| API Name | Vornorexant |
|---|---|
| CAS No | 1381971-84-1 |
| Molecular Formula | C13H14FN3O |
| Molecular Weight | 247.27 g/mol |
| Synonyms | 5-fluoro-2-[2-(oxan-2-yl)pyrazol-3-yl]pyridine |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Vornorexant is a dual orexin receptor antagonist (DORA) being developed by Taisho Pharmaceutical for the treatment of insomnia and sleep apnea. 5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine is a key intermediate in the synthesis of vornerexant (also known as ORN-0829 or TS-142).
The CAS number of 5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine is 1381971-84-1.
The molecular formula of 5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine is C13H14FN3O.
The listed molecular weight of 5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine is 247.27 g/mol.
5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine is listed as being used in connection with the following API: Vornorexant.
The listed synonym or IUPAC name for 5-Fluoro-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]pyridine is 5-fluoro-2-[2-(oxan-2-yl)pyrazol-3-yl]pyridine.